Lipid Balance Must Be Just Right to Prevent Development of Severe Liver Damage
Overview
Authors
Affiliations
Nonalcoholic fatty liver disease (NAFLD) is a major health concern that often associates with obesity and diabetes. Fatty liver is usually a benign condition, yet a fraction of individuals progress to severe forms of liver damage, including nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). Elevated sterol regulatory element-binding protein-driven (SREBP-driven) hepatocyte lipid synthesis is associated with NAFLD in humans and mice. In this issue of the JCI, Kawamura, Matsushita, et al. evaluated the role of SREBP-dependent lipid synthesis in the development of NAFLD, NASH, and HCC in the phosphatase and tensin homolog-knockout (PTEN-knockout) NASH model. Deletion of the gene encoding SREBP cleavage-activating protein (SCAP) from the liver resulted in decreased hepatic lipids, as expected. However, SCAP deletion accelerated progression to more severe liver damage, including NASH and HCC. This study provides a note of caution for those pursuing de novo fat biosynthesis as a therapeutic intervention in human NASH.
Lai P, Miao G, Zhao Y, Han Y, Li Y, Liu Y Nat Commun. 2025; 16(1):2430.
PMID: 40069146 PMC: 11897346. DOI: 10.1038/s41467-025-57585-0.
Lu Q, La M, Wang Z, Huang J, Zhu J, Zhang D Int J Mol Sci. 2025; 26(1.
PMID: 39795910 PMC: 11719989. DOI: 10.3390/ijms26010050.
Xie Q, Zeng Y, Zhang X, Yu F Cancer Immunol Immunother. 2024; 73(9):171.
PMID: 38954021 PMC: 11220057. DOI: 10.1007/s00262-024-03748-9.
Liang M, Huo M, Guo Y, Zhang Y, Xiao X, Xv J Front Pharmacol. 2022; 13:1084435.
PMID: 36518663 PMC: 9742474. DOI: 10.3389/fphar.2022.1084435.